- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04597333
Labor Induction After Failed Induction With Dinoprostone.
April 19, 2022 updated by: ROY LAUTERBACH MD, Rambam Health Care Campus
Comparison of Cervical Ripening Balloon Versus 2nd Dinoprostone Insert for Labor Induction in Women With a Failed 1st Attempt of Induction With Dinoprostone.
Women after induction of labor with a dinoprostone insert will be evaluated after 24 hours from the beginning of labor induction.
Women with a BISHOP score of less than 5 will be randomized to 1 of 2 groups.
Induction with a cervical ripening balloon versus induction with a 2nd dinoprostone insert.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Nulliparous women with obstetric indications for induction of labor who were induced with a dinoprostone insert and failed to go into labor after 24 hours from the beginning of labor induction and a BISHOP score of less than 5 will receive a thorough explanation regarding the study and sign informed consent.
The eligible women will be randomized to 1 of 2 groups.
Induction with a cervical ripening balloon versus induction with a 2nd dinoprostone insert.
Relevant demographic and medical information will be gathered from the patients' electronic files.
Study Type
Interventional
Enrollment (Actual)
144
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Haifa, Israel
- Rambam Health Care Campus
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 43 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women after induction of labor with Dinoprostone.
- BISHOP score of under 5 after 1st induction attempt.
- Nulliparous women.
Exclusion Criteria:
- Women after induction of labor with a cervical ripening balloon.
- BISHOP score of over 5 after 1st induction attempt.
- Multiparous women.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 2nd Dinoprostone.
Women induced with a second dinoprostone insert.
|
Dinoprostone vaginal insert.
|
Active Comparator: Cervical ripening balloon.
Women induced with a cervical ripening balloon.
|
Double lumen cervical ripening balloon.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Delivery within 24 hours.
Time Frame: From the time of induction up to 24 hours from induction.
|
Rate of delivery in 24 hours.
|
From the time of induction up to 24 hours from induction.
|
Time to delivery.
Time Frame: From the time of induction up to 120 hours from induction.
|
The number of hours it takes to deliver.
|
From the time of induction up to 120 hours from induction.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mode of delivery.
Time Frame: From the time of induction up to 120 hours from induction.
|
Vaginal and cesarean delivery rates.
|
From the time of induction up to 120 hours from induction.
|
Uterine revision.
Time Frame: From the time of induction up to 120 hours from induction.
|
The rate of uterine revision postpartum.
|
From the time of induction up to 120 hours from induction.
|
Postpartum hemorrhage.
Time Frame: From the time of induction up to 120 hours from induction.
|
The rate of postpartum hemorrhage.
|
From the time of induction up to 120 hours from induction.
|
Chorioamnionitis.
Time Frame: From the time of induction up to 120 hours from induction.
|
The rate of chorioamnionitis.
|
From the time of induction up to 120 hours from induction.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 15, 2020
Primary Completion (Actual)
November 30, 2021
Study Completion (Actual)
December 31, 2021
Study Registration Dates
First Submitted
October 15, 2020
First Submitted That Met QC Criteria
October 15, 2020
First Posted (Actual)
October 22, 2020
Study Record Updates
Last Update Posted (Actual)
April 20, 2022
Last Update Submitted That Met QC Criteria
April 19, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0009-20-RMB
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Induction of Labor Affected Fetus / Newborn
-
Holy Family Hospital, Nazareth, IsraelRecruitingInduction of Labor Affected Fetus / NewbornIsrael
-
Meir Medical CenterActive, not recruitingInduction of Labor Affected Fetus / NewbornIsrael
-
Wake Forest University Health SciencesCompletedInduction of Labor Affected Fetus / NewbornUnited States
-
Rambam Health Care CampusCompletedInduction of Labor Affected Fetus / NewbornIsrael
-
Intermountain Health Care, Inc.Ferring PharmaceuticalsTerminatedInduction of Labor Affected Fetus / NewbornUnited States
-
Ascension Genesys HospitalCompletedInduction of Labor Affected Fetus / NewbornUnited States
-
Ain Shams Maternity HospitalUnknownInduction of Labor Affected Fetus / NewbornEgypt
-
Ain Shams Maternity HospitalDr. Ahmed S. Abd El-Hameed; Prof. Abdel-Megeeed I. Abdel- MegeeedCompletedInduction of Labor Affected Fetus / NewbornEgypt
-
Ain Shams UniversityCompletedInduction of Labor Affected Fetus / Newborn
-
Hawaii Pacific HealthRecruitingInduction of Labor Affected Fetus / NewbornUnited States
Clinical Trials on Dinoprostone
-
Seoul National University HospitalCompletedNulliparous Women Who Scheduled for Labor InductionKorea, Republic of
-
Cairo UniversityCompletedDinoprostone TimingEgypt
-
Università degli Studi di BresciaCompletedLabor, Induced | Cervical RipeningItaly
-
Hospital Universitario 12 de OctubreInstituto de Salud Carlos III; Spanish Clinical Research Network - SCReNRecruitingFetal Growth RetardationSpain
-
Mednax Center for Research, Education, Quality...Completed
-
Intermountain Health Care, Inc.Ferring PharmaceuticalsTerminatedInduction of Labor Affected Fetus / NewbornUnited States
-
Weill Medical College of Cornell UniversityCompletedCervical Ripening | Labor InductionUnited States
-
Zeynep Kamil Maternity and Pediatric Research and...CompletedEarly Amniotomy, Unfavorable CervixTurkey
-
Cairo UniversityCompletedIntrauterine DeviceEgypt
-
Clinical Hospital MerkurCompletedInduction of Labor Affected Fetus / Newborn | Prostaglandins Causing Adverse Effects in Therapeutic UseCroatia